One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
Pakistan primarily imports Di-Ammonium Phosphate (DAP), Nitrogen Phosphate Potassium (NPK) to fulfill agriculture needs. Due ...
Johnson & Johnson (NYSE: JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-ADVANCE 1 and 2 and ICONIC-LEAD studies, which assessed the efficacy and safety of ICOTYDE™ ...
Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...
As the Iran-US-Israel conflict intensifies, multiple flashpoints are emerging across the region, signalling a dangerous ...
Thousands of Pittsburgh-area elementary and middle school students got to witness a world premiere performance at Heinz Hall.
Falmouth Packet on MSN
Easyjet to start new routes from Cornwall this summer
One month after a decision was made to discontinue Skybus flights from Newquay to London, a major airline has announced it will now be offering a new connection to the capital ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults furt ...
From the get-go it's a shocker of a lawsuit, starting with the parties involved, Board of County Commissioners of the County ...
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of ...
Lilly's Ebglyss delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis: Indianapolis Monday, March 30, 2026, 12:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results